<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: We sought to examine whether type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> increases risk of <z:hpo ids='HP_0011420'>death</z:hpo> and complications following <z:hpo ids='HP_0002090'>pneumonia</z:hpo> and to assess the prognostic value of admission <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: This was a population-based cohort study of adults with a first-time hospitalization for <z:hpo ids='HP_0002090'>pneumonia</z:hpo> between 1997 and 2004 (n = 29,900) in northern Denmark </plain></SENT>
<SENT sid="2" pm="."><plain>Information on <z:mp ids='MP_0002055'>diabetes</z:mp>, comorbidity, laboratory findings, pulmonary complications, and <z:e sem="disease" ids="C0004610" disease_type="Disease or Syndrome" abbrv="">bacteremia</z:e> was obtained from medical databases </plain></SENT>
<SENT sid="3" pm="."><plain>We used regression to compute adjusted relative risks of pulmonary complications, <z:e sem="disease" ids="C0004610" disease_type="Disease or Syndrome" abbrv="">bacteremia</z:e>, and mortality rate ratios (MRRs) within 90 days following hospitalization among patients with and without type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The prognostic impact of admission <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> was studied in a subcohort (n = 13,574) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: In total, 2,931 (9.8%) <z:hpo ids='HP_0002090'>pneumonia</z:hpo> patients had type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>Mortality among diabetic patients was greater than that among other patients: 19.9 vs. 15.1% after 30 days and 27.0 vs. 21.6% after 90 days, respectively, corresponding to adjusted 30- and 90-day MRRs of 1.16 (95% CI 1.07-1.27) and 1.10 (1.02-1.18) </plain></SENT>
<SENT sid="7" pm="."><plain>Presence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> did not predict pulmonary complications or <z:e sem="disease" ids="C0004610" disease_type="Disease or Syndrome" abbrv="">bacteremia</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Adjustment for <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> attenuated the association between type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and mortality </plain></SENT>
<SENT sid="9" pm="."><plain>High <z:chebi fb="105" ids="17234">glucose</z:chebi> level on admission was a predictor of <z:hpo ids='HP_0011420'>death</z:hpo> among patients with <z:mp ids='MP_0002055'>diabetes</z:mp> and more so among those without diagnosed <z:mp ids='MP_0002055'>diabetes</z:mp>: adjusted 30-day MRRs for <z:chebi fb="105" ids="17234">glucose</z:chebi> level &gt;or=14 mmol/l were 1.46 (1.01-2.12) and 1.91 (1.40-2.61), respectively </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and admission <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo> predict increased <z:hpo ids='HP_0002090'>pneumonia</z:hpo>-related mortality </plain></SENT>
</text></document>